๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit

RecruitingPhase 4Ages 18 Years - anyAllBeni-Suef University
NCT07642076 on ClinicalTrials.gov โ†—
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age more than 18 years old * male or female with confirmed liver disease admitted to intensive care unit, including: * Acute-on-chronic liver failure (ACLF) * Hepatic encephalopathy * spontaneous bacterial peritonitis (SBP) * variceal bleeding * fulminant hepatitis * Hepatorenal syndrome * Ascites * Etc Exclusion Criteria: * Age of less than 18 years old * Pregnancy or Lactation * patients have seizure * patient on warfarin
๐Ÿ’Š

What it tests

  • L Carnitine
  • Standard medical treatment
๐Ÿ“

Where

1 site
National liver institute
Shibฤซn al Kawm, Egypt
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy